Frailty adversely affects health and quality of life of people with HIV (PWH). A multidisciplinary-team (MDT) was established to perform a Comprehensive Geriatric Assessment (CGA) and to address modifiable risk factors in elderly PWH.
Methods
PWH aged over 80 years were reviewed by a dedicated HIV/geriatric clinic at Chelsea and Westminster Hospital. Descriptive statistics were used to report the variables of interest.
Results
Sixty-three PWH were reviewed, with a median age of 82 (IQR 80–86). Fifty-seven (88%) were men. The median number of co-morbidities was five (IQR 4–7) and polypharmacy was seen in 55 (85%), with a median of six (IQR 5–8) co-medications reported. The median Rockwood Clinical Frailty Score was two (IQR 2–5). Antiretrovirals were modernised in 18 (29%) individuals; co-medication changes and de-prescribing was recommended in 39 (62%).
Conclusion
A MDT approach helped reducing polypharmacy and frailty, suggesting that specialised tools and MDT input are key to identify medical and social concerns in elderly PWH.
TrickeyASabinCABurkholderG, et al.Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV2023; 10(5): e295–e307. DOI: 10.1016/S2352-3018(23)00028-0.
2.
LevettTAlfordKRobertsJ, et al.Evaluation of a combined HIV and geriatrics clinic for older people living with HIV: the silver clinic in Brighton, UK. Geriatrics2020; 5(4): 81. DOI: 10.3390/geriatrics5040081.
3.
SmitMBrinkmanKGeerlingsS, et al.Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis2015; 15: 810–818. DOI: 10.1016/S1473-3099(15)00056-0.
4.
GreeneMJusticeACCovinskyKE. Assessment of geriatric syndromes and physical function in people living with HIV. Virulence2017; 8(5): 586–598. DOI: 10.1080/21505594.2016.1245269.
5.
SongXMitnitskiARockwoodK. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc2010; 58(4): 681–687. DOI: 10.1111/j.1532-5415.2010.02764.x.
6.
FriedLPTangenCMWalstonJCardiovascular Health Study Collaborative Research Group, et al.Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci2001; 56(3): M146–M156. DOI: 10.1093/gerona/56.3.m146.
7.
ConroySThomasM. Urgent care for older people. Age Ageing2022; 51(1): afab019. DOI: 10.1093/ageing/afab019.
8.
CleggABatesCYoungJ, et al.Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing2016; 45(3): 353–360. DOI: 10.1093/ageing/afw039.
9.
RockwoodKMitnitskiASongX, et al.Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc2006; 54(6): 975–979. DOI: 10.1111/j.1532-5415.2006.00738.x.
10.
SangarlangkarnAAppelbaumJS. Comprehensive geriatric assessment in older persons with HIV. Open Forum Infect Dis2020; 7(11): ofaa485. DOI: 10.1093/ofid/ofaa485.
11.
NozzaSMalagoliAMaiaLGEPPO Study Group, et al.Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. J Antimicrob Chemother2017; 72(10): 2879–2886. DOI: 10.1093/jac/dkx169.
12.
RudermanSANanceRMDrumrightLN, et al.Development of frail RISC-HIV: a risk score for predicting frailty risk in the short-term for care of people with HIV. AIDS2023; 37(6): 967–975. DOI: 10.1097/QAD.0000000000003501.
13.
RittMSchwarzCKronawitterV, et al.Analysis of Rockwood et Al’s clinical frailty scale and fried et al’s frailty phenotype as predictors of mortality and other clinical outcomes in older patients who were admitted to a geriatric ward. J Nutr Health Aging2015; 19(10): 1043–1048. DOI: 10.1007/s12603-015-0667-9.
14.
ZhangXMJiaoJCaoJ, et al.Frailty as a predictor of mortality among patients with COVID-19: a systematic review and meta-analysis. BMC Geriatr2021; 21(1): 186. DOI: 10.1186/s12877-021-02138-5.
EllisGGardnerMTsiachristasA, et al.Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev2017; 9(9): CD006211. DOI: 10.1002/14651858.CD006211.pub3.
17.
PereiraBMazzitelliMMilinkovicA, et al.Evaluation of a clinic dedicated to people aging with HIV at Chelsea and westminster hospital: results of a 10-year experience. AIDS Res Hum Retrovir2022; 38(3): 188–197. DOI: 10.1089/AID.2021.0083.
18.
DavisAJGreeneMSieglerE, et al.Strengths and challenges of various models of geriatric consultation for older adults living with human immunodeficiency virus. Clin Infect Dis2022; 74(6): 1101–1106. DOI: 10.1093/cid/ciab682.
Joint FormularyCommittee.British National Formulary (online). Feb 2020 ed. London: BMJ Group and Pharmaceutical Press; 2020. Available fromhttp://www.medicinescomplete.com(cited 2023 September 25).
KingRRabinoS. ACB calculator. Available fromhttps://www.acbcalc.com/(updated 2024 July 03; cited 2023 September 25).
24.
Ministries of Housing, Communities & Local Government. English indices of deprivation 2019. London: Ministries of Housing, Communities & Local Government. https://imd-by-postcode.opendatacommunities.org/imd/2019, accessed on 10 October 2023).
25.
O’MahonyDO’SullivanDByrneS, et al.STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing2015; 44(2): 213–218. DOI: 10.1093/ageing/afu145.
26.
HodgesJRLarnerAJ. Cognitive screening instruments: a practical approach. 2nd ed.Berlin, Alemania: Springer, 2017, pp. 109–137. Addenbrooke’s Cognitive Examinations: ACE, ACE-R, ACE-III, ACEapp, and M-ACE.
27.
HalloranMBoyleCKehoeB, et al.Polypharmacy and drug–drug interactions in older and younger people living with HIV: the POPPY study. Antivir Ther2019; 24: 193–201.
28.
GreeneMSteinmanMAMcNichollIR, et al.Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc2014; 62(3): 447–453. DOI: 10.1111/jgs.12695.
29.
Gutiérrez-ValenciaMIzquierdoMCesariM, et al.The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol2018; 84(7): 1432–1444. DOI: 10.1111/bcp.13590.
30.
JakemanBScherrerABattegayM, et al.Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study. J Antimicrob Chemother2022; 77(2): 492–499. DOI: 10.1093/jac/dkab386.
31.
HuangWYangASTsaiDH, et al.Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study. BMJ2023; 382: e076045.
32.
GreeneMCovinskyKEValcourV, et al.Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr2015; 69(2): 161–167. DOI: 10.1097/QAI.0000000000000556.
33.
Clair-SullivanNSBristoweKKhanI, et al.Implementation of frailty screening for older people living with HIV in Brighton, UK. HIV Med2023. DOI: 10.1111/hiv.13598.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
